Integrated Biopharma Inc SEC filings INBP
Integrated Biopharma Inc has 557 filings in SEC EDGAR's recent list, going back to Nov 21, 1996. Its latest annual report, Form 10-K, was filed on Sep 25, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 8, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 25, 2026 (results of operations). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-K | Annual report | Sep 25, 2026 | Jun 30, 2026 |
| 10-K | Annual report | Sep 23, 2025 | Jun 30, 2025 |
| 10-K | Annual report | Sep 20, 2024 | Jun 30, 2024 |
| 10-K | Annual report | Sep 15, 2023 | Jun 30, 2023 |
| 10-K | Annual report | Sep 13, 2022 | Jun 30, 2022 |
| 10-K | Annual report | Sep 2, 2021 | Jun 30, 2021 |
| 10-K | Annual report | Sep 23, 2020 | Jun 30, 2020 |
| 10-K | Annual report | Aug 29, 2019 | Jun 30, 2019 |
| 10-K | Annual report | Sep 12, 2018 | Jun 30, 2018 |
| 10-K | Annual report | Sep 1, 2017 | Jun 30, 2017 |
| 10-K | Annual report | Sep 2, 2016 | Jun 30, 2016 |
| 10-K | Annual report | Sep 4, 2015 | Jun 30, 2015 |
| 10-K | Annual report | Sep 8, 2014 | Jun 30, 2014 |
| 10-K | Annual report | Sep 30, 2013 | Jun 30, 2013 |
| 10-K | Annual report | Oct 15, 2012 | Jun 30, 2012 |
| 10-K | Annual report | Oct 13, 2011 | Jun 30, 2011 |
| 10-K/A | Amended annual report | Sep 29, 2010 | Jun 30, 2010 |
| 10-K | Annual report | Sep 28, 2010 | Jun 30, 2010 |
| ARS | Annual report to shareholders | Nov 25, 2009 | Jun 30, 2009 |
| 10-K | Annual report | Oct 13, 2009 | Jun 30, 2009 |
| 10-K | Annual report | Oct 14, 2008 | Jun 30, 2008 |
| 10-K | Annual report | Sep 28, 2007 | Jun 30, 2007 |
| 10-K | Annual report | Sep 28, 2006 | Jun 30, 2006 |
| 10-K | Annual report | Sep 28, 2004 | Jun 30, 2004 |
| ARS | Annual report to shareholders | Nov 7, 1997 | Jun 30, 1997 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INBP (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Hillside, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1016504
- Former names
- INTEGRATED HEALTH TECHNOLOGIES INC (until Apr 16, 2003); CHEM INTERNATIONAL INC (until May 14, 2002)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.